Corporate, or "strategic," investors are busy making digital health investments in smaller companies as they seek to fortify their presence in that important space. So far 2014 boasts about 70 deals worth $800 million, easily exceeding last year's total. Deal volume is nearly double that of 2012.
In another sign Siemens is pivoting away from healthcare and towards the energy industry, the German conglomerate announced the sale of its hearing aid business for $2.69 billion to private equity firm EQT Partners and Santo Holding, the investment company of Germany's Strüngmann family.
Covidien CEO José Almeida said during the company's fiscal Q4 earnings call that the company's looming megamerger with Medtronic will give the combined entity "a voice at the table" due to its volume in some of the most purchased devices in the world.
As med tech outfits race to develop innovative, noninvasive technology for diabetes monitoring, Dexcom snagged FDA approval for a new artificial pancreas algorithm for its continuous glucose monitoring device.
Stryker has agreed to shell out at least $4.38 billion to settle more than 4,000 lawsuits alleging the medical device giant sold faulty metal hip implants that hurt patients.
More than two dozen lawsuits related to the distribution and use of counterfeit spinal screws and hardware implanted in patients were filed Friday in Los Angeles Superior Court, claiming a former hospital executive and his business partners were in on the conspiracy.
The Centers for Medicare & Medicaid Services recently finalized a change toughening the transparency promoting the Sunshine Act, designed to collection information on pharma and med tech payments made to doctors.
The Republican takeover of the Senate means the chances of a repeal of the medical device tax are improved, but the Congressional Research Service just gave supporters of the tax ammunition. This week it released to the public a report claiming the medical device tax will only result in a 0.2% decrease in device industry jobs and output.
Medtronic is celebrating positive study results for its drug-coated balloon device for peripheral artery disease, days after Covidien announced that it would sell off its own drug-coated balloon to clear the way for the companies' pending merger.
The watchdog agency of the Department of Health and Human Services promised to crackdown on defective medical devices and cybersecurity in hospitals in its recently released agenda for fiscal year 2015.
A former Boston Scientific engineer has been indicted by a federal grand jury for stealing documents from the giant device maker that he allegedly planned to use to set up a manufacturing business in Vietnam and market the products in the U.S. and elsewhere under a new name.
Cantel Medical has picked up Italian healthcare manufacturing company International Medical Service S.r.l. (IMS) for €19.6 ($24.5 million), making it the second major acquisition for the New Jersey-based maker of infection prevention and control systems in the past four months.
Maryland's Technology Development Corp. is dishing out funds for startups and early stage digital health companies. Overall, 15 med tech companies received a total of $1.5 million.
Integra LifeSciences provided the reorganization-of-the-day today as the industry shakeup continues amid continuing med tech merger mania. The Plainsboro, NJ, company announced plans to spin off its spine business into a new publicly traded company dubbed SeaSpine focused on selling spinal implants and orthobiologics.
Covidien won FDA 510(k) clearance for its directional atherectomy devices for peripheral artery disease, a notch in the company's belt as it anticipates the close of its pending $43 billion deal with Medtronic.
Kimberly-Clark spinoff Halyard Health, and its suite of protective gear, is a beneficiary of the Ebola fears striking West Africa and the U.S. airwaves. The stock is up a little more than a dollar since Monday's IPO, and stands at $38.72 on the New York Stock Exchange prior to market open today.
Gauss Surgical, maker of a real-time monitor app for blood loss during surgery, raised $1.5 million by selling equity in the company. The total offering could go as high as $2 million, according to a SEC filing.
ReShape Medical said about a year ago that it had positive U.S. pivotal obesity data for its ReShape Integrated Dual Balloon. Now it has offered a glimpse of that data for the first time, ahead of an FDA review that's expected to come during the first half of 2015.
When the Jumpstart Our Business Startups (JOBS) Act became law, no one was quite sure what, if anything, it would do in practice to encourage the financing of innovative companies. One firm is plowing ahead into this uncharted territory, aiming to push beyond the often consumer-oriented efforts of major crowdfunding sites like Kickstarter and Indiegogo.
Medical device startup Force Impact Technologies designed a mouthguard that can provide real-time alerts on concussions during high-impact activities to coaches and medical professionals.